Plasma Fractionation Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Application (Neurology, Immunology, Hematology, Pulmonology), By End-User (Hospitals And Clinics, Academic & Research Institutes), And By Geography - Forecasts From 2021 To 2026

Published:  Dec 2021 Report Code: KSI061611770 Pages: 124

The plasma fractionation market is expected to grow at a compound annual growth rate of 7.21% over the forecast period to reach a market size of US$35.405 billion in 2026, from US$21.748 billion in 2019. The market is expected to surge in the coming years, due to the rise in the prevalence rate of chronic diseases, the increasing rate of the geriatric population, and other related factors. The surge in the development of diagnostic and healthcare facilities is also anticipated to facilitate market growth, in the coming years. But, the high cost of plasma derivatives is one of the major factors, that could hinder the market growth in low developing nations. 

North America is expected to have a major share in the market, due to the rise in the research and development intending in the development of novel solutions. The presence of some of the major players in the region is also expected to facilitate market growth. In the coming years, Asia Pacific is also expected to register a significant CAGR, due to the increase in the development of novel and advanced healthcare and diagnostic facilities.

Increasing prevalence rate of chronic diseases

The market is expected to surge in the coming years, due to the rising prevalence rate of chronic diseases, worldwide. According to the data given by the Food & Agriculture Organisation and the World Health Organisation, it was estimated and projected that chronic diseases would account for around 3/4 of all deaths, globally, by the year 2020. The plasma fractionation market is expected to surge, as the rate of chronic diseases has been accelerating at a considerable rate. 

The rising popularity of blood plasma fractionation

There has been a surge in the popularity of blood plasma fractionation, worldwide, in the past few years. Blood usually comprises about 55% plasma, and around 44% red blood cells. The demand is expected to surge, due to the rise in the number of blood banks, as the blood is collected and then the plasma is separated to complete the process called blood plasma fractionation. There has also been a surge in the therapeutic uses of blood plasma fractionation, which is expected to play a major role in the market growth. According to the data given by the Government of India, there are around 2,700 blood banks in the nation, that have been collecting around 10 million units of blood, per year. These trends are projected to play a considerable role in the market growth, in the coming years. 

Competitive Analysis

There have been several players that have been offering plasma fractionation solutions for their customers. For instance, Octapharma, one of the imperative players in the market, has been collecting plasma from donors and then producing it into a life-saving therapy. The company had stated that their plasma-derived therapy had been completely purified, monitored, controlled, and inspected before the use. Other players, such as GE Healthcare and CSL Ltd., are also expected to play a key role in the market growth, in the coming years. 

Plasma Fractionation Market Scope:

Report Metric Details
 Market size value in 2019  US$21.748 billion
 Market size value in 2026  US$35.405 billion
 Growth Rate  CAGR of 7.21% from 2019 to 2026
 Base year  2019
 Forecast period  2021–2026
 Forecast Unit (Value)  USD Billion
 Segments covered  Application, End-User, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered  Octapharma AG, GE Healthcare, Merck KGaA, Grifols SA, CSL Ltd., Biotest,   Sanquin, Takeda Pharmaceutical Company, Kedrion, Bio Products Laboratory
 Customization scope  Free report customization with purchase

Segmentation:

  • By Application
    • Neurology
    • Immunology
    • Hematology
    • Pulmonology
  • By End-User
    • Hospitals & Clinics
    • Academic & Research Institutes
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Israel
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Thailand
      • Taiwan
      • Indonesia
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the plasma fractionation market size by 2026?
A1. The plasma fractionation market is expected to reach a market size of US$35.405 billion by 2026.


Q2. What are the growth prospects for the plasma fractionation market?
A2. The global plasma fractionation market is expected to grow at a CAGR of 7.21% during the forecast period.


Q3. Which region holds the maximum market share of the plasma fractionation market?
A3. North America is expected to have a major share in the plasma fractionation market, due to the rise in the research and development intending in the development of novel solutions.


Q4. What is the size of the global plasma fractionation market?
A4. Plasma Fractionation Market was valued at US$21.748 billion in 2019.


Q5. What factors are anticipated to drive the plasma fractionation market growth?
A5. The plasma fractionation market is expected to surge in the coming years, due to the rise in the prevalence rate of chronic diseases, the increasing rate of the geriatric population, and other related factors.

1. Introduction
1.1. Market Overview
1.2. Covid-19 Scenario
1.3. Market Definition
1.4. Market Segmentation

2. Research Methodology
2.1. Research Data
2.2. Assumptions

3. Executive Summary
3.1. Research Highlights

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Plasma Fractionation Market Analysis, By Application 
5.1. Introduction
5.2. Neurology
5.3. Immunology
5.4. Hematology
5.5. Pulmonology

6. Plasma Fractionation Market Analysis, By End User 
6.1. Introduction
6.2. Hospitals & Clinics
6.3. Academic & Research Institutes

7. Plasma Fractionation Market Analysis, By Geography 
7.1.  Introduction
7.2.  North America
7.2.1. United States
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. UK
7.4.2. France
7.4.3. Germany
7.4.4. Spain
7.4.5. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Israel
7.5.4. Others
7.6. Asia Pacific
7.6.1. Japan
7.6.2. China
7.6.3. India
7.6.4. South Korea
7.6.5. Thailand
7.6.6. Taiwan
7.6.7. Indonesia
7.6.8. Others

8.  Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2.  Emerging Players and Market Lucrativeness
8.3.  Mergers, Acquisitions, Agreements, and Collaborations
8.4.  Vendor Competitiveness Matrix

9. Company Profiles
9.1. Octapharma AG
9.2. GE Healthcare
9.3. Merck KGaA
9.4. Grifols SA
9.5. CSL Ltd.
9.6. Biotest
9.7. Sanquin
9.8. Takeda Pharmaceutical Company
9.9. Kedrion
9.10. Bio Products Laboratory

Octapharma AG

GE Healthcare

Merck KGaA

Grifols SA

CSL Ltd.

Biotest

Sanquin

Takeda Pharmaceutical Company

Kedrion

Bio Products Laboratory

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us